Clinical Trials Directory

Trials / Completed

CompletedNCT01149941

Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition

Randomized, 2-way Crossover, Bioequivalence Study of Ibuprofen 200 mg Gel Capsules and Advil Liquigels 200 mg Gel Capsules Administered as 1 x 200 mg Gel Capsules in Healthy Subjects Under Fasting Conditions

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Dr. Reddy's Laboratories Limited · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the rate and extent of absorption of ibuprofen 200 mg gelcaps (test) versus Advil liquigels (reference) administered as 1 x 200 mg gelcap under fasting conditions.

Detailed description

Randomized, 2-way crossover, bioequivalence study of Ibuprofen 200 mg gel capsules and Advil liquigels 200 mg gel caps administered as 1 x 200 mg gel capsule in healthy subjects under fasting conditions.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofenIbuprofen 200 mg gel capsules of Dr. Reddy's Laboratories Limited

Timeline

Start date
2002-11-01
Primary completion
2002-11-01
Completion
2002-11-01
First posted
2010-06-24
Last updated
2010-06-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01149941. Inclusion in this directory is not an endorsement.

Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition (NCT01149941) · Clinical Trials Directory